In vitro penetration of the dopamine D2 agonist N-0923 with and without Azone
- 10 November 1992
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 87 (1) , 67-72
- https://doi.org/10.1016/0378-5173(92)90228-t
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Impact of Structural Differences on thein VitroGlucuronidation Kinetics of Potentially Dopaminergic Hydroxy‐2‐Aminotetralins and Naphthoxazines Using Rat and Human Liver MicrosomesBasic & Clinical Pharmacology & Toxicology, 1991
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolitesXenobiotica, 1990
- Mode of action of penetration enhancers in human skinJournal of Controlled Release, 1987
- The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approachJournal of Controlled Release, 1987
- Vehicle effect on topical drug delivery. III. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycolInternational Journal of Pharmaceutics, 1985
- Percutaneous Absorption. On the Relevance of in Vitro DataJournal of Investigative Dermatology, 1975